BLINCYTO (blinatumomab) - Important Safety Information from AMGEN Ireland Ltd as approved by the HPRA (September 2019)

Notice type: 3rd Party Publications

Date: 05/09/2019

 

Problem Or Issue:

Important Safety Information from AMGEN Ireland Limited regarding clarification of premedication with dexamethasone in paediatric patients - BLINCYTO (blinatumomab)

 

Important Safety Information - BLINCYTO (blinatumomab)



« Back